Analysis of mural cell recruitment to tumor vessels

Circulation

Volumn 105, Issue 1, 2002, Pages 112-117

  Abramsson, A ^a   Berlin, O ^a   Papayan, H ^a   Paulin, D ^a   Shani, M ^a   Betsholtz, C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Angiogenesis; Cells; Growth substances; Muscle, smooth; Pericytes

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; MOUSE; MURAL CELL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; ANTIGENS, CD31; CELL LINE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, NUDE; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036140857     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0102.101437     Document Type: Article

References (31)

1. Tumor angiogenesis: Therapeutic implications
2. Angiogenesis in cancer and other diseases
3. Clinical applications of angiogenic growth factors and their inhibitors
4. Determinants of tumor blood flow: A review
5. Openings between defective endothelial cells explain tumor vessel leakiness
6. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
7. VEGF gene delivery to the myocardium: Deleterious effects of unregulated expression
8. VEGF gene therapy: Stimulating angiogenesis or angiomagenesis?
9. Differential expression of markers for endothelial cells, pericytes and basal lamina in the microvasculature of tumors and granulation tissue
10. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
11. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis
12. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
13. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate
14. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
15. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
16. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis
17. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities
18. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
19. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells
20. A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells
21. Modulation of the sis gene transcript during endothelial cell differentiation in vitro
22. Defective angiogenesis in mice lacking endoglin
23. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis
24. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
25. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
26. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic development
27. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice
28. Retention of PDGFR-beta function in mice in the absence of phosphatidylinositol 3′-kinase and phospholipase C signaling pathways
29. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions
30. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic therapies